手术联合I125粒子术中植入在颅内肿瘤治疗中的应用

摘要

Objective To discuss the efficacy of surgery combined with intra-operative I125 particles implantation in treatment of intracranial tumor.Methods The data of 25 cases diagnosed with intracranial tumors in general hospital of Shenyang Military Region from January 2015 to November 2016 were retrospectively analyzed.All patients received the combination of surgery and I125 particles intra-operative implantation.The therapeutic effect was observed and evaluated.Results All the patients were followed up for 6 to 18 months and there was no signs of recurrence or adverse reactions in the short term.Conclusion The combination of surgery and I125 particles intra-operative implantation could avoid the pain of postoperative radiotherapy and inhibit the short-term recurrence of multiple intracranial tumors.%目的 探讨手术联合I125粒子术中植入对颅内肿瘤治疗的效果.方法 回顾性分析沈阳军区总医院2015年1月至2016年11月确诊为颅内肿瘤并采用手术联合I125粒子术中植入治疗的25例患者的临床资料,观察该方法治疗的效果,并作出评价.结果 所有患者术后随访6～18个月,肿瘤在短期内均无复发倾向,无明显不良反应.结论 手术联合I125粒子术中植入将内放射治疗与手术治疗相结合,使患者术后免于接受外放射治疗的痛苦,对多种颅内肿瘤的短期复发有较好的抑制作用.